Cargando…

Caracterización molecular de pacientes con cáncer colorrectal

INTRODUCTION: Colorectal cancer has a high incidence in the world population. Different molecular pathways, such as chromosomal instability, microsatellite instability, and epigenetics are involved in its development. OBJECTIVE: To perform molecular characterization in 44 individuals with sporadic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Humberto Afanador, Carlos, Palacio, Katherine Andrea, Isaza, Luis Fernando, Ahumada, Enoc, Ocampo, Carlos Mauricio, Muñetón, Carlos Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Nacional de Salud 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414253/
https://www.ncbi.nlm.nih.gov/pubmed/35866738
http://dx.doi.org/10.7705/biomedica.5957
Descripción
Sumario:INTRODUCTION: Colorectal cancer has a high incidence in the world population. Different molecular pathways, such as chromosomal instability, microsatellite instability, and epigenetics are involved in its development. OBJECTIVE: To perform molecular characterization in 44 individuals with sporadic colorectal cancer. MATERIALS AND METHODS: We conducted mutation analyses of the APC, KRAS, TP53 y BRAF genes using Sanger sequencing techniques; microsatellite instability was determined by capillary electrophoresis with five STR genetic markers while the methylation status of the MHL1 promotor gene was analyzed using methylation-specific PCR. RESULTS: APC, KRAS, and TP53 genes mutation frequency was 18.1%, 25%, and 4.5%, respectively; the somatic mutations detected were located more frequently in the right colon. The frequency of microsatellite instability was 27.2% and 73.1% of the tumors had the MHL1 gene methylated while 91.6% of microsatellite instability-positive tumors had the methylated MLH1 gene. The mutation profile of microsatellite stability tumors APC, KRAS, and TP53 genes was more frequent than in the microsatellite instability-positive tumors. The methylation of the MLH1 gene was the most predominant molecular alteration. CONCLUSIONS: We identified molecular alterations in different genetic pathways of the colorectal cancer patients evaluated, which are common in the carcinogenesis of this cancer. These patients showed a different mutational profile compared to other populations. Our findings confirm the molecular heterogeneity described in the development of colorectal cancer.